ICH E2A Clinical Safety Data Management

Target entity: ICH E2A Clinical Safety Data Management
Context triple: [International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, notableWork, ICH E2A Clinical Safety Data Management]

• A. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
  The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
• B. Integrating the Healthcare Enterprise
  Integrating the Healthcare Enterprise (IHE) is an initiative by healthcare professionals and industry to improve the way computer systems in healthcare share information by promoting the coordinated use of established standards.
• C. Management Board of the European Medicines Agency
  The Management Board of the European Medicines Agency is the governing body that oversees the agency’s strategy, budget, and overall operations in regulating medicines within the European Union.
• D. IHE Patient Care Device profiles
  IHE Patient Care Device profiles are interoperability specifications that define how medical devices integrate and exchange data within healthcare IT systems to support safe, coordinated patient care.
• E. Clinical Practices of the University of Pennsylvania
  Clinical Practices of the University of Pennsylvania is the faculty practice plan and outpatient clinical arm of Penn Medicine, providing patient care across a wide range of specialties in collaboration with the University of Pennsylvania’s health system.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Target entity: ICH E2A Clinical Safety Data Management
Target entity description: ICH E2A Clinical Safety Data Management is an international guideline that standardizes the collection, reporting, and evaluation of clinical safety data in drug development to support consistent pharmacovigilance and regulatory decision-making.

• A. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
  The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
• B. Integrating the Healthcare Enterprise
  Integrating the Healthcare Enterprise (IHE) is an initiative by healthcare professionals and industry to improve the way computer systems in healthcare share information by promoting the coordinated use of established standards.
• C. Management Board of the European Medicines Agency
  The Management Board of the European Medicines Agency is the governing body that oversees the agency’s strategy, budget, and overall operations in regulating medicines within the European Union.
• D. IHE Patient Care Device profiles
  IHE Patient Care Device profiles are interoperability specifications that define how medical devices integrate and exchange data within healthcare IT systems to support safe, coordinated patient care.
• E. Clinical Practices of the University of Pennsylvania
  Clinical Practices of the University of Pennsylvania is the faculty practice plan and outpatient clinical arm of Penn Medicine, providing patient care across a wide range of specialties in collaboration with the University of Pennsylvania’s health system.
• F. None of above. chosen